Core Viewpoint - The stock of Insilico Medicine (03696) rose nearly 5%, reaching a new high of 42.66 HKD per share, driven by the announcement of the DORA Community Edition, a free AI engine aimed at enhancing scientific research and content creation [1] Group 1: Product Launch and Features - Insilico Medicine launched the DORA Community Edition, a comprehensive AI engine designed for scientific research and content creation, which is free and can be self-deployed [1] - The DORA Community Edition aims to democratize access to cutting-edge research tools, promoting global scientific collaboration and increasing transparency in scientific research [1] - The upgraded DORA integrates seamlessly with various Foundry models, including the O3 Deep Research model, significantly enhancing the efficiency and quality of scientific content creation [1] Group 2: Additional Offerings - In addition to the Community Edition, Insilico Medicine offers a more comprehensive DORA SaaS version for users with advanced and specialized needs [1] - The DORA SaaS version provides access to pre-analyzed "protein-disease association" reports from Insilico's PandaOmics target discovery engine, offering deeper domain-specific insights [1] - The SaaS version connects to Insilico's data warehouse, supporting instant in-text citations [1]

Core Viewpoint - The launch of DORA Community Edition by Insilico Medicine aims to enhance global scientific collaboration and innovation in biotechnology and academia through a free, self-deployable AI engine supported by Microsoft [1][2] Group 1: Product Launch and Features - Insilico Medicine's stock rose nearly 5%, reaching a new high of 42.66 HKD following the announcement of DORA Community Edition [1] - DORA Community Edition is designed for scientific research and content creation, promoting transparency and accelerating innovation in the biotech and academic sectors [1] - The upgraded DORA integrates seamlessly with various Foundry models, including the O3 Deep Research model, significantly improving research content creation efficiency and output quality [1] Group 2: Advanced Offerings - In addition to the Community Edition, Insilico Medicine offers a more comprehensive DORA SaaS version for users with advanced, specialized needs [2] - The DORA SaaS version provides access to pre-analyzed "protein-disease association" reports from the PandaOmics target discovery engine, offering deeper domain-specific insights [2] - It connects to Insilico Medicine's data warehouse, supporting instant in-text citations [2]